Craig Adam R's Form 4 filing
Cti Biopharma Corp (CTIC) · filed Jul 6, 2022
- Accession no.
- 0000891293-22-000034
- Filed
- Jul 6, 2022
- Trade date
- Jun 30-Jul 6, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $435.3K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Craig Adam RCIK 0001339498 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | common stock | AGrant or awardAcquired | +6,183 | $2.12 | +$13,107.96 | 22,861 | Direct | |
| Jul 1, 2022 | common stock | MOption exerciseAcquired | +27,000 | $0.84 | +$22,680 | 49,861 | Direct | |
| Jul 1, 2022 | common stock | SSaleDisposed | −27,000 | $6.00 | −$162,000 | 22,861 | Direct | |
| Jul 5, 2022 | common stock | MOption exerciseAcquired | +27,000 | $0.84 | +$22,680 | 49,861 | Direct | |
| Jul 5, 2022 | common stock | SSaleDisposed | −27,000 | $6.00 | −$162,000 | 22,861 | Direct | |
| Jul 6, 2022 | common stock | MOption exerciseAcquired | +18,223 | $0.84 | +$15,307.32 | 41,084 | Direct | |
| Jul 6, 2022 | common stock | SSaleDisposed | −18,223 | $6.11 | −$111,342.53 | 22,861 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | Common Stock | MOption exerciseDisposed | −27,000 | $0.00 | $0 | 1,200,777 | Direct | |
| Jul 5, 2022 | Common Stock | MOption exerciseDisposed | −27,000 | $0.00 | $0 | 1,173,777 | Direct | |
| Jul 6, 2022 | Common Stock | MOption exerciseDisposed | −18,223 | $0.00 | $0 | 1,155,554 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.